Teva Pharmaceutical Industries Limited (TEVA)
Management Succession Transcript
January 3, 2012 8:30 AM ET

Executives

Kevin Mannix – Vice President, Head, Corporate Investor Relations
Dr. Jeremy Levin – President and CEO
Shlomo Yanai – President and CEO
Dr. Phillip Frost – Chairman
Eyal Desheh – Chief Financial Officer
Bill Marth – President and CEO, Teva Americas

Analysts

Jami Rubin – Goldman Sachs
Ken Cacciatore – Cowen And Company
John Boris – Citi
Chris Schott – JPMorgan
Ronny Gal – Bernstein
Shibani Malhotra – RBC Capital
Louise Chen – Colling Stewart
Randall Stanicky – Canaccord
Michael Faerm – Credit Suisse
David Buck – Buckingham Research Group
Gregg Gilbert – Bank of America
Marc Goodman – UBS
Corey Davis – Jefferies
David Risinger – Morgan Stanley
Michael Tong – Wells Forgo
Douglas Tsao – Barclays Capital
Tim Chiang – CRT Capital
Jason Gerberry – Leerink Swann

Presentation

Operator

Good day, ladies andComplete Story »